Bluegrass Vascular Closes $5 Mil Convertible Debt Financing
Funding will support the acceleration of the commercial expansion of Bluegrass Vascular’s Surfacer® System.
Medical device and diagnostics companies are always looking for ways to improve their products and services. In the ever-changing landscape of the healthcare industry, it’s essential for these companies to stay ahead of the curve. That’s why funding is always news.
Series A, B, and other rounds of funding are essential for medical device and diagnostics companies. They provide the necessary capital to help these businesses grow and innovate. And with so many investors interested in this space, there are plenty of opportunities for companies to secure the funding they need.
Funding will support the acceleration of the commercial expansion of Bluegrass Vascular’s Surfacer® System.
“Pristine Surgical has brought the endoscope into the 21st Century, improving the endoscopic procedure for both patient and surgeon,” said Mark Goldwasser, CEO of Ceros Financial Services.
Net proceeds from the financing will be used to operationalize and scale commercialization of the Evoke® Spinal Cord Simulation System (SCS) for chronic pain.
Copyright © 2025 Medical Device News Magazine, a division of PTM Healthcare Marketing, Inc. All Rights Reserved
Hours:
M – F 8 am – 5 pm ET
Florida / New York
Phone: 561.316.3330